| 6.565 0.095 (1.47%) | 10-09 15:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8 |
1-year : | 9.34 |
| Resists | First : | 6.84 |
Second : | 8 |
| Pivot price | 6.62 |
|||
| Supports | First : | 6.49 |
Second : | 6.28 |
| MAs | MA(5) : | 6.63  |
MA(20) : | 6.55 |
| MA(100) : | 6.39 |
MA(250) : | 6.92 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 46 |
D(3) : | 58.9 |
| RSI | RSI(14): 53 |
|||
| 52-week | High : | 9.23 | Low : | 6.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AUNA ] has closed above bottom band by 40.6%. Bollinger Bands are 36.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.66 - 6.71 | 6.71 - 6.75 |
| Low: | 6.34 - 6.4 | 6.4 - 6.44 |
| Close: | 6.39 - 6.48 | 6.48 - 6.55 |
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Thu, 09 Oct 2025
Is Auna S.A. stock entering bullish territory - July 2025 Volume & Trade Opportunity Analysis - newser.com
Tue, 07 Oct 2025
Auna S.A. (NYSE:AUNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Wed, 01 Oct 2025
Auna SA Class A Ordinary Shares (NYSE:AUNA) Stock Quote - FinancialContent
Wed, 24 Sep 2025
Auna Continues to Increase OncoMexico Network’s Nationwide Presence Through Partnerships with Leading Medical Institutions - businesswire.com
Sat, 20 Sep 2025
Auna S.A. Reports 2Q25 Financial Results with Positive FX-Neutral EBITDA Growth - MSN
Wed, 20 Aug 2025
Auna S.A. (AUNA) Beats Q2 Earnings Estimates - sharewise.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 0 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 2.336e+007 (%) |
| Held by Institutions | 24 (%) |
| Shares Short | 180 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.94 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 68.9 |
| Profit Margin | 5.5 % |
| Operating Margin | 16 % |
| Return on Assets (ttm) | 6.2 % |
| Return on Equity (ttm) | 14.3 % |
| Qtrly Rev. Growth | -2.5 % |
| Gross Profit (p.s.) | 56.14 |
| Sales Per Share | 144.51 |
| EBITDA (p.s.) | 30 |
| Qtrly Earnings Growth | 2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 649 (M) |
| PE Ratio | 6.92 |
| PEG Ratio | 0 |
| Price to Book value | 0.09 |
| Price to Sales | 0.04 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 154590 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|